XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 290,895 $ 114,846
Investment securities, available-for-sale 111,978 301,977
Accounts receivable, net 65,915 62,195
Interest and other receivables 4,335 885
Inventory 6,095 6,636
Prepaid expenses 23,632 21,398
Total current assets 502,850 507,937
Property and equipment, net 5,595 6,021
Operating lease right-of-use assets 54,151 55,573
Intangible assets, net 69,583 0
Restricted cash 5,770 5,770
Long-term inventory 4,924 4,924
Other assets 12,432 7,587
Total assets 655,305 587,812
Liabilities and stockholders’ equity    
Accounts payable 17,422 12,746
Accrued liabilities 206,879 112,884
Total current liabilities 224,301 125,630
Operating lease liabilities 51,441 52,695
Other long-term liabilities 5,305 9,074
Total liabilities 281,047 187,399
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at March 31, 2023 and December 31, 2022; no shares issued and outstanding at March 31, 2023 and December 31, 2022 0 0
Common stock, $0.0001 par value; 225,000,000 shares authorized at March 31, 2023 and December 31, 2022; 162,384,178 shares and 162,064,872 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively. 16 16
Additional paid-in capital 2,787,034 2,770,923
Accumulated deficit (2,412,572) (2,369,551)
Accumulated other comprehensive loss (220) (975)
Total stockholders’ equity 374,258 400,413
Total liabilities and stockholders’ equity $ 655,305 $ 587,812